Skip to main content
AVR
NASDAQ Industrial Applications And Services

Anteris Technologies Launches $250M At-The-Market Equity Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.16
Mkt Cap
$936.432M
52W Low
$2.85
52W High
$9.79
52W Position info
221% above low
Off High info
6.4% below high
Rel. Volume info
2.4× avg
Market data snapshot near publication time

AVR has more than doubled off its 52-week low of $2.85 on elevated volume (2.4× avg).

Summary

Anteris Technologies Global Corp. launched a new At-The-Market (ATM) offering to sell up to $250 million of common stock, providing significant capital for product development but also posing substantial dilution risk.


Key Events · Financing and Capital Events · AVR

  • New At-The-Market (ATM) Offering

    Anteris Technologies Global Corp. entered into a sales agreement with TD Securities (USA) LLC to offer and sell up to $250 million of common stock through an At-The-Market program.

  • Significant Potential Dilution

    The offering represents a potential capital raise of approximately 26.7% of the company's current market capitalization. If the full amount were sold at an assumed price of $9.00 per share, it would result in an immediate dilution of $4.84 per share for new investors and a potential increase of approximately 28.5% in outstanding shares.

  • Use of Proceeds

    Net proceeds are intended primarily for the ongoing development of the DurAVR® THV System, with the remainder allocated to working capital and general corporate purposes.

  • Follows Prior Capital Raise

    This new ATM program follows a previously reported $320 million capital raise, further strengthening the company's financial runway amidst prior going concern warnings.


Analysis · AVR · Industrial Applications And Services

Anteris Technologies Global Corp. has established a new At-The-Market (ATM) equity program to sell up to $250 million in common stock. This represents a substantial potential capital raise, equivalent to approximately 26.7% of the company's current market capitalization, and could result in significant dilution for existing shareholders. While dilutive, this capital is crucial for a development-stage medical technology company like Anteris, particularly following previous disclosures of a going concern warning and recent Q1 2026 results that highlighted a prior $320 million capital raise. The proceeds are earmarked for the ongoing development of its DurAVR® THV System and general corporate purposes, extending its financial runway.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AVR was trading at $9.16 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $936.4M. The 52-week trading range was $2.85 to $9.79. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AVR - Latest Insights

AVR
Nov 10, 2026, 5:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.90
Real-time Price: $5.36 info
Change: -$0.540 (-9%) info
Market Cap: $518.665M info
AVR
Nov 10, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.89
Real-time Price: $5.36 info
Change: -$0.530 (-9%) info
Market Cap: $518.665M info
AVR
Oct 06, 2026, 6:18 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.51
Real-time Price: $5.36 info
Change: -$2.15 (-29%) info
Market Cap: $518.665M info
AVR
Oct 01, 2026, 8:09 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $7.61
Real-time Price: $5.36 info
Change: -$2.25 (-30%) info
Market Cap: $518.665M info
AVR
Aug 12, 2026, 6:13 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $8.84
Real-time Price: $5.36 info
Change: -$3.48 (-39%) info
Market Cap: $518.665M info